|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.35 USD | +2.62% |
|
-0.42% | -53.00% |
| Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
| Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
AC Immune SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CHF 14.8 million compared to CHF 3.94 million a year ago. Net loss was CHF 54.23 million compared to CHF 70.75 million a year ago.
Basic loss per share from continuing operations was CHF 0.64 compared to CHF 0.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -53.00% | 221M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
AC IMMUNE SA 
